The Conscious Fund and Ambria Capital, LLC Provides Funding to Support Wesana Health Entry into the Emerging Psychedelics Space
January 21, 2021 at 12:30 pm
Wesana Health has announced the $4 million round, led by The Conscious Fund and Ambria Capital, LLC, provides funding to support the company's entry into the emerging psychedelics space. The proceeds will allow Wesana to begin preclinical and clinical work on the use of psychedelic-assisted therapy to treat traumatic brain injury (TBI) as well as regulatory applications including Investigational New Drug (IND) filings with the Food and Drug Administration (FDA), and Investigational Medicinal Product Dossier (IMPD) filings with Health Canada. In addition, the funds will support the build out of Wesana's staffing and senior leadership teams.